This article is more than 5 years old. Information may no longer be current.
Ace the Case: A 52-Year-Old Patient With Rheumatoid Arthritis Who Had an Inadequate Response to Methotrexate and a Tumor Necrosis Factor Inhibitor
Click Here to Manage Email Alerts
This educational activity will utilize a case study to discuss the management of a 52-year-old patient with rheumatoid arthritis (RA) who had inadequate response to methotrexate and a tumor necrosis factor (TNF) inhibitor.
Case Presentation
Chief Complaint: Rheumatoid arthritis (RA) with worsening symptoms despite taking methotrexate and a tumor necrosis factor (TNF) inhibitor.
History of Present Illness: Ms. S., a 52-year-old teacher and mother of two, was diagnosed with RA (seropositive for rheumatoid factor [RF] and anti-cyclic citrullinated peptide [anti-CCP]) with high disease activity. After initial therapy with methotrexate 15 mg weekly over a 3-month period failed to substantially improve her joint pain and swelling, she was prescribed adalimumab 40 mg every other week. At her next 3-month evaluation, her joint pain and swelling had still not improved significantly.
Learning Objectives:
Upon successful completion of this educational activity, participants will be better able to:
- Manage patients with RA following an inadequate response to methotrexate and a TNF inhibitor.
Overview:
Author(s)/Faculty: Gregg Silverman, MD
Source: Healio Rheumatology Education Lab
Type: Monograph
Articles/Items: 4
Release Date: 1/15/2019
Expiration Date: 1/14/2020
Credit Type: CME / ABIM MOC
Number of Credits: 0.25
Cost: Free
Provider: Vindico Medical Education
CME Information
Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Support Statement: There is no commercial support for this activity.
Target Audience: The intended audience for this activity is rheumatologists and other health care professionals.
Click here to view this activity.